Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WESTLAKE CORP Director's Dealing 2021

Mar 10, 2021

30551_dirs_2021-03-10_211286c4-b838-4be5-88ae-5a96a66b8856.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WESTLAKE CHEMICAL CORP (WLK)
CIK: 0001262823
Period of Report: 2021-03-09

Reporting Person: Bender Mark Steven (EVP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-09 Common Stock M 9816 $63.9775 Acquired 41196 Direct
2021-03-09 Common Stock M 15995 $61.865 Acquired 57191 Direct
2021-03-09 Common Stock S 25811 $92.2719 Disposed 31380 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-09 Employee Option (right to buy) $63.9775 M 9816 Disposed 2024-02-14 Common Stock (9816) Direct
2021-03-09 Employee Option (right to buy) $61.865 M 15995 Disposed 2027-02-17 Common Stock (15995) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $92.00 to $92.95, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: The stock options are excercisable in three installments of 33%, 33% and 34% on February 14, 2015, 2016 and 2017.

F3: The stock options are excercisable in three installments of 33%, 33% and 34% on February 17, 2018, 2019 and 2020.